Recent News

• 08.04.2026 - InfuSystem Announces Financial Results for Second Quarter 2026
• 08.04.2026 - Investor Presentation
• 07.28.2026 - InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
• 05.18.2026 - InfuSystem Announces $20 Million Stock Repurchase Program
• 05.07.2026 - InfuSystem Announces Financial Results for First Quarter 2026
• 04.30.2026 - InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026
• 03.16.2026 - InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026
• 02.24.2026 - InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
• 02.17.2026 - InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
• 12.10.2025 - Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026

Recent Filings

• 08.04.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.04.2026 - 8-K Current report
• 08.04.2026 - 8-K Current report
• 08.04.2026 - EX-99.1 EX-99.1
• 08.04.2026 - EX-99.1 EX-99.1
• 07.28.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.28.2026 - 8-K Current report
• 07.28.2026 - EX-99.1 EX-99.1
• 05.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2026 - 4 Statement of changes in beneficial ownership of securities